Clinical Trials Browser

INDUSTRY × Lymphoma × olaratumab × Clear all

NCT00768391 2011-06-28

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Phase 1 Completed

Lymphoma, Neoplasms